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n December 2003, PLoS Biology 
published a research article 
reporting evidence of an association 
between a gene called GAD2 and 
susceptibility to obesity (DOI: 10.1371/
journal.pbio.0000068). Although the 
genetic data were suggestive rather 
than conclusive, the editors and 
reviewers supported publication because 
unambiguous evidence in association 
studies is notoriously difﬁ  cult to obtain 
and obesity is such a major burden 
on public health. Enthusiasm was 
heightened because GAD2 lies in a 
region of human Chromosome 10 that 
is thought to contain a gene inﬂ  uencing 
obesity, and GAD2 itself is involved in 
the synthesis of a neurotransmitter 
implicated in the regulation of food 
intake. Publication would allow others to 
test just how important the connection 
between GAD2 and obesity might 
be—and the enticing prospect was that 
insight into the role of GAD2 in this 
disease might lead ultimately to new 
therapeutic approaches.
In this issue of PLoS Biology, we 
publish a follow-up to the original study, 
from a separate team of researchers 
based at the University of California at 
San Francisco (DOI: 10.1371/journal.
pbio.0030315). Swarbrick et al. looked 
at different and much larger patient 
populations and analyzed variation 
within GAD2 more comprehensively, but 
disappointingly, the new study was not 
able to replicate the initial ﬁ  nding. 
Despite the negative conclusions, 
however, the reviewers were no less 
enthusiastic about the publication of 
this paper than the ﬁ  rst. One of the 
reasons for this is related to a problem 
that has beset the ﬁ  eld of complex 
disease genetics for several years—a 
tendency towards the publication of 
studies that show an association. 
Diseases are termed complex 
when their etiology is inﬂ  uenced 
by many factors, both genetic and 
environmental. These diseases include 
obesity, diabetes, mental illness, and 
many more common ailments. But 
ﬁ  nding the genes that are involved with 
these diseases is an extremely difﬁ  cult 
problem: individual genes have only a 
limited effect, which means that large 
patient populations need to be studied; 
speciﬁ  c genes might have effects only 
in certain ethnic groups; and statistical 
artifacts can be hard to eliminate. 
These and other problems mean that 
success stories are few and far between, 
whereas false leads have been plentiful. 
High-proﬁ  le journals, in particular, 
have therefore tended to publish the 
positive results, whereas negative data 
often end up in specialist literature or, 
much worse, don’t get published at all.
Because the identiﬁ  cation of a 
complex disease gene is so difﬁ  cult, the 
ﬁ  rst positive report is rarely deﬁ  nitive—
replication studies that use independent 
populations with sample sizes large 
enough to detect the expected effects 
are necessary to bolster (or undermine) 
the case. A bias towards publishing 
positive results might therefore 
perpetuate the false impression that a 
gene is indeed associated with a disease. 
In a ﬁ  eld this complex, such bias is 
entirely unhelpful.
Replication studies are therefore 
vital to the ﬁ  eld of human genetics, 
and at PLoS Biology, we’ve taken the 
view that well-designed, and high-
powered replication studies can 
be just as worthy of publication in 
the journal as the initial ﬁ  nding of 
a genetic association—and PLoS’s 
community journal PLoS Genetics takes 
a similar view. The new paper on 
GAD2 demonstrates this point—the 
study was judged by the reviewers to be 
sufﬁ  ciently large and well conducted to 
provide a robust test of the hypothesis 
that variation in GAD2 is involved—
above a certain minimum effect—in 
susceptibility to obesity. The negative 
conclusion suggests that researchers 
now need to consider possible reasons 
for the variability in results such as 
sample or phenotype differences, 
or else examine the possibility that 
other variants in the Chromosome 10 
region might be involved in obesity.
It might ultimately be that the initial 
ﬁ  nding simply does not hold in larger 
samples. That replication papers are 
important for the ﬁ  eld is supported 
by the publication of another large 
study in type 2 diabetes (DOI: 10.1371/
journal.pbio.0000020), which included 
replication data, and has already been 
cited 28 times.
Would editorial opinion of the 
paper by Swarbrick et al. have been any 
different if the result had been positive? 
We think not, because the ﬁ  rst study 
left sufﬁ  cient room for doubt, and a 
positive result could have been just as 
signiﬁ  cant. In general, then, we will 
judge a replication paper on its merits, 
and consider whether the submitted 
work provides a major advance on the 
previous genetic ﬁ  ndings. 
But PLoS Biology and PLoS Genetics 
are both highly selective journals. 
By themselves they cannot solve the 
problem, and will only publish the most 
signiﬁ  cant association studies—whether 
the results are positive or negative. 
Furthermore, the accumulation of 
genetic association data is likely only to 
accelerate in the coming years, thanks 
to major collaborative efforts such as 
the SNP Consortium (http:⁄⁄snp.cshl.
org) and the International HapMap 
Project (http:⁄⁄www.hapmap.org). 
Public availability of these rich resources 
will stimulate genome-wide efforts to 
map the genes underlying any number 
of complex disorders. Data will abound, 
and they need to be published and 
also made publicly available. Most of 
the individual studies will not provide 
deﬁ  nitive evidence of associations, but 
as the data build, meta-analyses will 
become more and more informative.
PLoS is currently exploring the 
possibility of providing further 
publication opportunities to extend 
the venues that are available for 
association studies. As with all PLoS 
articles, the data and the associated 
papers would be freely available 
to read and reanalyze. With the 
introduction of more such open-access 
publications and with support from 
the community, it would be possible 
to eliminate bias in the publication of 
association studies for good.  
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